Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2003
07/31/2003WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses
07/31/2003WO2002024897A3 Conditionally replicating viral vectors and their use
07/31/2003WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003US20030144517 Chiral fluoroquinolone arginine salt forms
07/31/2003US20030144503 Antiinflammatory agents
07/31/2003US20030144486 Monoclonal human natural antibodies
07/31/2003US20030144485 Monoclonal human natural antibodies
07/31/2003US20030144474 T cell receptor and a biologically active polypeptide with different recognition biding sites connected by a peptide linker; designed to redirect the immune system against various diseases
07/31/2003US20030144337 Pyrazole-derived kinase inhibitors and uses thereof
07/31/2003US20030144334 Cyclopentabenzofuran derivatives and their use
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144309 Inhibitors of Src and other protein kinases
07/31/2003US20030144307 2,6-Disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease
07/31/2003US20030144303 Aminopyrimidine and aminopyridine anti-inflammation agents
07/31/2003US20030144302 Process for making substituted pyrazoles
07/31/2003US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
07/31/2003US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144283 Amide substituted imidazoquinolines
07/31/2003US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals
07/31/2003US20030144279 5-Heterocyclo-pyrazoles
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144267 Novel compounds
07/31/2003US20030144265 HIV protease inhibitors based on amino acid derivatives
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/31/2003US20030144250 Triazole derivatives useful in therapy
07/31/2003US20030144249 Aminoalkylenephosphoxide derivatives, useful as bactericide, fungicide, viricide and parasiticide
07/31/2003US20030144247 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
07/31/2003US20030144246 Chromenylmethyl pyrimidinediamines as antibacterial agents
07/31/2003US20030144239 Expression system
07/31/2003US20030144232 Expression system
07/31/2003US20030144217 Prodrugs of aspartyl protease inhibitors
07/31/2003US20030144210 Treatment of neurologic and psychiatric disorders
07/31/2003US20030144198 Increasing gastrointestinal absorption
07/31/2003US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product
07/31/2003US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin
07/31/2003US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes
07/31/2003US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening
07/31/2003US20030143620 Carbohydrate ligands specific for MHC molecules
07/31/2003US20030143589 Drug metabolizing enzymes
07/31/2003US20030143528 Vector for analayzing replication mechanism of rna virus and use thereof
07/31/2003US20030143522 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins
07/31/2003US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection
07/31/2003US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
07/31/2003US20030143247 For therapy of infections with hepatitis or picornaviruses
07/31/2003US20030143246 Ganoderma lucidum spores for treatment of autoimmune diseases
07/31/2003US20030143245 Multivalent streptococcal vaccine compositions and methods for use
07/31/2003US20030143243 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/31/2003US20030143241 For inhibiting hepatitis E virus (HEV) infection
07/31/2003US20030143234 For therapy of microbial organism infection
07/31/2003US20030143223 Modulating the activity of one or more elements in the complement/lipid pathway
07/31/2003US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin
07/31/2003US20030143209 For gene therapy of cancers or cardiovascular conditions
07/31/2003US20030143197 Administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal
07/31/2003US20030143192 Chemokine beta-7
07/31/2003US20030143189 Therapy for topical diseases
07/31/2003US20030143185 Polymer conjugates of protein kinase C inhibitors
07/31/2003US20030143162 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
07/31/2003US20030143157 Method of treating tumors
07/31/2003CA2840490A1 Polyalkylene glycol with moiety for conjugating biologically active compounds
07/31/2003CA2753899A1 Polyalkylene glycol with moiety for conjugating biologically active compounds
07/31/2003CA2510751A1 Multimers of receptor-binding ligands
07/31/2003CA2486588A1 Method for the production of resveratrol in cell cultures
07/31/2003CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003CA2474292A1 Sustained release pharmaceutical composition
07/31/2003CA2473944A1 Methods and compositions for rna interference
07/31/2003CA2473906A1 Cooperative oligonucleotides
07/31/2003CA2473799A1 Triterpene quaternary salts as biologically active surfactants
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473781A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003CA2473508A1 Pyrimidinone viral polymerase inhibitors
07/31/2003CA2473490A1 Peptide-carrying bodies for immune response
07/31/2003CA2473420A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003CA2473395A1 Phospholipid bodies and use thereof in medical treatment
07/31/2003CA2473254A1 Combination therapy for the treatment of bacterial infections
07/31/2003CA2473032A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
07/31/2003CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472564A1 Aqueous antiseptic composition comprising an antimicrobial agent, a high concentration of a hydroxycarboxylic acid buffer, and a cationic film-forming polymer
07/31/2003CA2471749A1 Biocidal compounds and their preparation
07/31/2003CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003CA2471383A1 Amido macrolides
07/31/2003CA2466266A1 Novel substituted alkane compounds and uses thereof
07/30/2003EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
07/30/2003EP1331270A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
07/30/2003EP1331268A1 Novel proteins, genes encoding them and method of using the same
07/30/2003EP1331223A1 Method of treating sepsis
07/30/2003EP1330538A2 Cd36 as a heat shock protein receptor and uses thereof
07/30/2003EP1330467A2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity
07/30/2003EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
07/30/2003EP1330442A1 Phthalazinone derivatives
07/30/2003EP1330441A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections
07/30/2003EP1330425A2 C-nitroso compounds and use thereof
07/30/2003EP1330292A2 Radioactive member for use in brachytherapy and method of making
07/30/2003EP1330268A1 Targeted therapeutic agents
07/30/2003EP1330259A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy
07/30/2003EP1330240A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
1 ... 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 ... 1798